These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans. Charles MA, Suzuki M, Waldeck N, Dodson LE, Slater L, Ong K, Kershnar A, Buckingham B, Golden M. J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213 [Abstract] [Full Text] [Related]
4. IgG subclasses of islet cell surface antibodies and their cytotoxic activity against pancreatic islet cells. Suzuki M, Kawazu S, Negishi K, Watanabe T, Hokama A, Fujiki Y, Takahashi Y, Ishii J. Diabetes Res Clin Pract; 1987 Mar; 3(4):215-20. PubMed ID: 3304909 [Abstract] [Full Text] [Related]
5. Serum C3 and C4 levels and complement-dependent antibody-mediated cytotoxic activity of islet cell surface antibody in type 1 (insulin-dependent) diabetic children. Okada S, Sato K, Miyai Y, Masaki Y, Higuchi T, Ogino Y, Ota Z. Diabetologia; 1987 Nov; 30(11):869-73. PubMed ID: 3328722 [Abstract] [Full Text] [Related]
8. Complement-fixing islet cell antibodies in type-1 diabetes can trigger the assembly of the terminal complement complex on human islet cells and are potentially cytotoxic. Radillo O, Nocera A, Leprini A, Barocci S, Mollnes TE, Pocecco M, Pausa M, Valente U, Betterle C, Tedesco F. Clin Immunol Immunopathol; 1996 Jun; 79(3):217-23. PubMed ID: 8635278 [Abstract] [Full Text] [Related]
14. Antibodies to the M(r) 64,000 (64K) protein in islet cell antibody positive non-diabetic individuals indicate high risk for impaired beta-cell function. Seissler J, Hering B, Richter W, Glück M, Yassin N, Bretzel RG, Boehm BO, Federlin K, Scherbaum WA. Diabetologia; 1992 Jun; 35(6):550-4. PubMed ID: 1612228 [Abstract] [Full Text] [Related]
15. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies. Grant AM, Harrison DE, Moysey L, Smith D, Ashcroft SJ. Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186 [Abstract] [Full Text] [Related]
16. Absence of cytotoxicity of islet cell surface antibodies in vivo despite complement-mediated cytotoxic effects to islet cells in vitro. Kohnert KD, Hehmke B, Fält K, Ziegler M. Biomed Biochim Acta; 1984 Sep; 43(5):663-73. PubMed ID: 6206850 [Abstract] [Full Text] [Related]
17. [Autoimmunity and viral infections in type-I diabetes mellitus]. Helmke K, Weimer R, Willems W, Otten A, Mäser E, Velcovsky HG, Federlin K. Dtsch Med Wochenschr; 1986 Mar 07; 111(10):369-73. PubMed ID: 3512225 [Abstract] [Full Text] [Related]
19. In vitro lysis of islet cells by lymphocytes from diabetic BB/Wor rats is not antibody mediated. Koevary SB. Diabetes Res; 1990 Mar 07; 13(3):133-8. PubMed ID: 2091881 [Abstract] [Full Text] [Related]